Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Divestments (2016 - 2017)

Historic Divestments for Lisata Therapeutics (LSTA) over the last 4 years, with Q4 2017 value amounting to -$82814.0.

  • Lisata Therapeutics' Divestments rose 9950.56% to -$82814.0 in Q4 2017 from the same period last year, while for Sep 2018 it was -$82814.0, marking a year-over-year decrease of 10014.29%. This contributed to the annual value of $74.6 million for FY2017, which is 436365.67% up from last year.
  • Lisata Therapeutics' Divestments amounted to -$82814.0 in Q4 2017, which was up 9950.56% from $4.4 million recorded in Q3 2017.
  • Lisata Therapeutics' 5-year Divestments high stood at $65.3 million for Q2 2017, and its period low was -$16.7 million during Q4 2016.